Logo Image

Video Shorts

The FDA Approval of Adjuvant Cemiplimab for High-Rish Cutaneous Squamous Cell Carcinoma
1:13
The FDA Approval of Adjuvant Cemiplimab for High-Rish Cutaneous Squamous Cell Carcinoma
a year ago
by
Vishal A. Patel, MD, FAAD, FACMS
Maurie Markman, MD
0:50
The Complexities of Cancer Care in the Elderly
a year ago
by
Maurie Markman, MD
Key Takeaways From MiBA 2025: AI in Oncology
0:22
Key Takeaways From MiBA 2025: The Future of AI in Oncology
a year ago
by
Omar Nadeem, MD
How Real-World Studies Address Gaps in Randomized Clinical Trial Data in mCRC
0:51
How Real-World Studies Address Gaps in Randomized Clinical Trial Data in mCRC
a year ago
by
Tanios S. Bekaii-Saab, MD
Morana Vojnic, MD, MBA, Rutgers Cancer Institute
1:23
Updates in Primary Brain Tumor Management
a year ago
by
Morana Vojnic, MD, MBA
Maurie Markman, MD
1:30
Decision Support in Oncology
a year ago
by
Maurie Markman, MD
Maurie Markman, MD
1:30
Making the Case for PFS Over OS in Clinical Trials
a year ago
by
Maurie Markman, MD
The Association Between HIV Status and Age at Presentation in Multiple Myeloma
0:54
The Association Between HIV Status and Age at Presentation in Multiple Myeloma
a year ago
by
Oatile Phakathi, MBChB, FC Orth (SA), MMed
Xavier Leleu, MD, PhD
2:01
The Role of Subcutaneous On-Body Delivery Systems in Myeloma Management
a year ago
by
Xavier Leleu, MD, PhD
The Push to Bring ctDNA to Clinical Practice for CRC
1:11
The Push to Bring ctDNA to Clinical Practice for CRC
a year ago
by
Mark A. Lewis, MD
Douglas Flora, MD
1:17
2025 MiBA Community Summit: Behind the Scenes
a year ago
by
Ashley Chan
First Annual International Brain Tumor Symposium: Experts Recap the Latest Advances in Brain Cancer
1:15
First Annual International Brain Tumor Symposium: Experts Recap the Latest Advances in Brain Cancer
a year ago
by
Kyle Doherty
Efficacy and Safety of Arlo-Cel for R/R Myeloma
1:33
The Efficacy and Safety of Arlo-Cel for R/R Myeloma
a year ago
by
Omar Nadeem, MD
All Eyes on DESTINY-Breast11 Readout for HER2+ Breast Cancer at ESMO 2025
1:00
All Eyes on DESTINY-Breast11 Readout for HER2+ Breast Cancer at ESMO 2025
a year ago
by
Paolo Tarantino, MD
Don't Ignore the Signs: Why Increased Awareness of Early Endometrial Cancer Symptoms Is Critical
0:53
Don't Ignore the Signs: Why Increased Awareness of Early Endometrial Cancer Symptoms Is Critical
a year ago
by
Dana Chase, MD
Is Early Mortality Associated With Real-World Bispecific Antibody Use in R/R Multiple Myeloma?
0:45
Is Early Mortality Associated With Real-World Bispecific Antibody Use in R/R Multiple Myeloma?
a year ago
by
Carlyn Rose Tan, MD
Jonathan H. Sherman, MD, FAANS, FCNS, FACS, Rutgers Cancer Institute
0:37
Unpacking Advances in the Surgical Management of Brain Cancer
a year ago
by
Jonathan H. Sherman, MD, FAANS, FCNS, FACS
Ryan M. Kahn, MD, MHS, FACOG, of Baptist Health Miami Cancer Institute
1:01
Ongoing Challenges With Surgery in Ovarian Cancer
a year ago
by
Ryan M. Khan, MD, MHS, FACOG
Michelle Monje, MD, PhD, of Stanford University
0:44
Using CAR T-Cell Therapy in Diffuse Midline Gliomas
a year ago
by
Michelle Monje, MD, PhD
John P. Diaz, MD, of Baptist Health
0:34
The Role of Minimally Invasive Surgery in Uterine Cancer
a year ago
by
John Paul Diaz, MD
Real-World Outcomes of Patients With Newly Diagnosed Multiple Myeloma Treated with Front-Line DRd
1:26
Real-World Outcomes of Patients With Newly Diagnosed Multiple Myeloma Treated with Front-Line DRd
a year ago
by
Ricardo D. Parrondo, MD
Maurie Markman, MD
1:24
Landmark Trials in Advanced Ovarian Cancer
a year ago
by
Maurie Markman, MD
2025 IMS Annual Meeting: Experts Recap Latest Advances in Multiple Myeloma
2:17
2025 IMS Annual Meeting: Experts Recap Latest Advances in Multiple Myeloma
a year ago
by
Ashling Wahner
Ken Culver, MD, and D. Ross Camidge, MD, PhD
2:29
Managing Strategic and Patient Expectations in R&D
a year ago
by
Ross Camidge, MD, PhD(+1 more)
Adam Lee, and D. Ross Camidge, MD, PhD
1:58
Are Health Economists Promotional?
a year ago
by
Ross Camidge, MD, PhD(+1 more)
Brandon Blue, MD, and D. Ross Camidge, MD, PhD
2:38
How I Became a Healer
a year ago
by
Ross Camidge, MD, PhD(+1 more)
Heather McArthur, MD, UT Southwestern Medical Center
0:25
Sac-TMT Plus Pembrolizumab in TNBC
a year ago
by
Heather McArthur, MD, MPH
Eric K. Singhi, MD, of MD Anderson Cancer Center
0:43
Recapping the IASLC 2025 World Conference on Lung Cancer
a year ago
by
Eric K. Singhi, MD
Mack Roach III, MD
0:34
How AI Is Reshaping Cancer Care
a year ago
by
Mack Roach III, MD
Joel Neal, MD, PhD
1:00
DNA- and RNA-Based Sequencing in Lung Cancer
a year ago
by
Joel Neal, MD, PhD